Island Pharmaceuticals Limited (ASX:ILA)

Island Pharmaceuticals Statistics

Total Valuation

ASX:ILA has a market cap or net worth of AUD 109.37 million. The enterprise value is 102.50 million.

Market Cap	109.37M
Enterprise Value	102.50M

Important Dates

The next estimated earnings date is Tuesday, May 26, 2026.

Earnings Date	May 26, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:ILA has 295.58 million shares outstanding. The number of shares has increased by 88.25% in one year.

Current Share Class	295.58M
Shares Outstanding	295.58M
Shares Change (YoY)	+88.25%
Shares Change (QoQ)	+24.50%
Owned by Insiders (%)	40.39%
Owned by Institutions (%)	4.60%
Float	150.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,740.07
PB Ratio	15.28
P/TBV Ratio	17.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-14.24
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.40

Current Ratio	8.40
Quick Ratio	8.21
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -130.31% and return on invested capital (ROIC) is -83.32%.

Return on Equity (ROE)	-130.31%
Return on Assets (ROA)	-74.67%
Return on Invested Capital (ROIC)	-83.32%
Return on Capital Employed (ROCE)	-102.89%
Weighted Average Cost of Capital (WACC)	4.94%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +111.43% in the last 52 weeks. The beta is 0.13, so ASX:ILA's price volatility has been lower than the market average.

Beta (5Y)	0.13
52-Week Price Change	+111.43%
50-Day Moving Average	0.40
200-Day Moving Average	0.35
Relative Strength Index (RSI)	42.12
Average Volume (20 Days)	413,405

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:ILA had revenue of AUD 62,851 and -7.20 million in losses. Loss per share was -0.03.

Revenue	62,851
Gross Profit	-1.99M
Operating Income	-7.36M
Pretax Income	-7.20M
Net Income	-7.20M
EBITDA	n/a
EBIT	-7.36M
Loss Per Share	-0.03

Balance Sheet

The company has 6.87 million in cash and n/a in debt, with a net cash position of 6.87 million or 0.02 per share.

Cash & Cash Equivalents	6.87M
Total Debt	n/a
Net Cash	6.87M
Net Cash Per Share	0.02
Equity (Book Value)	7.16M
Book Value Per Share	0.03
Working Capital	6.37M

Cash Flow

Operating Cash Flow	-3.67M
Capital Expenditures	n/a
Depreciation & Amortization	52,645
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-11,715.94%
Pretax Margin	-11,452.57%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:ILA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-88.25%
Shareholder Yield	-88.25%
Earnings Yield	-6.58%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:ILA has an Altman Z-Score of 35.76 and a Piotroski F-Score of 1.

Altman Z-Score	35.76
Piotroski F-Score	1